• The patent covers the composition of RHAMM-Binding peptides as well as the use of peptides for diagnosing, and determining the prognosis for, cancer patients. The is..
• Groundbreaking innovation has immediate market application in the catheter treatment of Atrial Fibrillation (AF), the most common irregular heartbeat affliction. ..
BridgeSat, Inc. Announces the Appointment of David Mitlyng as Senior Vice President of Business Development Boston (July 24, 2015) –..